Form 4: Intuitive Surgical EVP Curet Reports Stock Transactions

Intuitive Surgical's EVP & Chief Medical Officer, Myriam Curet, reported the vesting of restricted and performance stock units, leading to the acquisition and subsequent tax-related disposition of common stock.

Summary

• Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical Inc. (ISRG), reported multiple transactions on February 26, 2026, related to equity compensation.
• Acquired 3,052 shares of common stock through the vesting of Restricted Stock Units (RSUs) at an exercise price of $0.0.
• Disposed of 1,514 shares of common stock at a price of $506.17 per share to cover statutory tax withholding requirements associated with the RSU vesting.
• Acquired an additional 1,602 shares of common stock through the vesting of other RSUs at an exercise price of $0.0.
• Disposed of 795 shares of common stock at a price of $506.17 per share to cover statutory tax withholding requirements for these additional RSUs.
• Following these transactions, Myriam Curet beneficially owns 3,461 shares (indirectly by Trust) from the first RSU vesting and 1,947 shares (indirectly by Trust) after tax withholding.
• For the second RSU vesting, 3,549 shares (indirectly by Trust) were beneficially owned, and 2,754 shares (indirectly by Trust) after tax withholding.
• Performance Stock Units (PSUs) initially granted on February 28, 2023, for 2,793 shares, had their performance criteria achieved and are set to vest on February 28, 2026.
• Restricted Stock Units (RSUs) granted on February 26, 2024, for 3,052 shares, vest 33% per year over a three-year period.
• Restricted Stock Units (RSUs) granted on February 26, 2025, for 1,602 shares, vest 100% on the first anniversary of the grant date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, reflecting routine executive compensation activities rather than new strategic or operational developments for the company.

Positives

• Vesting of 3,052 shares and 1,602 shares of common stock from Restricted Stock Units (RSUs) at an exercise price of $0.0, increasing the executive's beneficial ownership.
• Achievement of performance criteria for 2,793 Performance Stock Units (PSUs) granted on February 28, 2023, which are scheduled to vest on February 28, 2026, indicating successful performance metrics.

Negatives

• Disposition of 1,514 shares and 795 shares of common stock at $506.17 per share to cover statutory tax withholding requirements, representing a sale of shares.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Provides transparency into executive compensation and ownership changes, which is a standard regulatory disclosure.

Next Steps

• Vesting of 2,793 Performance Stock Units (PSUs) on February 28, 2026, subject to continuous service.
• Future annual vesting of Restricted Stock Units (RSUs) granted on February 26, 2024, over a three-year period.

Key Dates

Keywords

Intuitive Surgical, ISRG, Form 4, Insider Transaction, Restricted Stock Units, Performance Stock Units, Equity Compensation, Stock Vesting, Executive Compensation